A simplified approach for purification of functional lactose permease from Escherichia coli is described that is based on the construction of chimeras between the permease and a 100-amino acid residue polypeptide containing the biotin acceptor domain from the oxaloacetate decarboxylase ofKlebsieUapneumoniae [Cronan, J. E., Jr. (1990)J. Biol. Chem. 265, 10327-10333]. Chimeras were constructed with a factor Xa protease site and the biotin acceptor domain in the middle cytoplasmic loop (loop 6) or at the C terminus of the permease. Each construct catalyzes active lactose transport in cells and right-side-out membrane vesicles. Moreover, the constructs are biotinylated in vivo, and in both chimeras, the factor Xa protease site is accessible from the cytoplasmic surface of the membrane. Both biotinylated permeases bind selectively to immobilized monomeric avidin and are eluted with free biotin in a high state of purity, and the loop 6 chimera catalyzes active transport after reconstitution into proteoliposomes. The methodology described should be applicable to other membrane proteins.
The lactose permease of Escherichia coli is a polytopic hydrophobic membrane protein that catalyzes the coupled translocation of a single ,B-galactoside molecule with a single H+ (i.e., symport or cotransport). As such, it is a paradigm for membrane proteins that transduce the energy stored in an electrochemical ion gradient into work in the form of a concentration gradient (see refs. 1 and 2 for reviews). The permease is encoded by the lacYgene, which has been cloned (3) and sequenced (4) , and the protein has been solubilized from the membrane, purified, and reconstituted into proteoliposomes in a fully functional state (5) . Based on circular dichroism of the purified protein and the sequential hydropathy of the deduced amino acid sequence (6), a secondary structure was proposed in which the polypeptide is organized into 12 a-helical domains that traverse the membrane in zigzag fashion connected by more hydrophilic domains (loops). Evidence supporting the general aspects ofthe model and demonstrating that both the N and C termini are on the cytoplasmic face of the membrane has been obtained through a variety of experimental approaches (1, 2) , and analysis of lactose permease-alkaline phosphatase (lacY-phoA) fusions has provided unequivocal support for the topological predictions of the 12-helix model (7) .
Although lactose permease can be solubilized from the membrane, purified, and reconstituted in a functional state, a simpler, more rapid purification is needed for biochemical and spectroscopic studies involving cysteine (8) (9) (10) (11) (12) or tryptophan (13) replacement mutants, as well as attempts at crystallization. Cronan (14) has described a method for the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
construction of soluble chimeric proteins from either E. coli or Saccharomyces cerevisiae with biotin acceptor domains from one offour different carboxylases fused to the C termini and demonstrated that the proteins are biotinylated in vivo. The biotinylated fusion proteins can be readily purified in native form by binding to columns of monomeric avidin followed by elution with buffers containing biotin. This report describes applications of the approach to lactose permease. Preliminary reports on some of this work have been presented (15, 16 Construction of Chimeras. (i) C-terminal biotin acceptor domain (CB permease). Plasmid pLacY/CB was constructed by using lacYfrom pGM21 (17) and pKR35 (19) as the source of DNA encoding the biotin acceptor domain. pGM21 has a 2.3-kb EcoRI fragment containing the lacYgene preceded by the lac promoter/operator and a Shine-Dalgarno sequence. By bacteriophage M13 site-directed mutagenesis (20) , an EcoRI site was introduced immediately upstream of the lac promoter/operator and a Sal I site was created at the 3' end of the lacY coding sequence. The Sal I site converts the codon for the last residue of the permease from alanine to aspartate. The new restriction sites uniquely flank a 1.5-kb DNA fragment containing the lac promoter/operator and the lacY gene and allow mobilization from M13 replicative-form (RF) DNA. pKR35 contains a 0.3-kb DNA fragment encoding the biotin acceptor domain from the Klebsiella pneumoniae oxaloacetate decarboxylase with an in-frame, unique Sal I site at the 5' end and a termination codon (TAA) at the 3' end. The plasmid also contains an EcoRI site upstream from the Sal I site. Thus, pKR35 was digested with EcoRI and Sal I and ligated with the 1.5-kb DNA fragment containing lacY obtained from M13 RF DNA digested with the same two restriction endonucleases, creating pLacY/CB. In this construct, the 3' end of lacY is fused in-frame with the 5' end of the DNA encoding the biotin acceptor domain.
(ii) Insertion offactor Xa protease site (CXB permease). The polymerase chain reaction (PCR) was used to introduce a factor Xa "restriction" protease site (Ile-Glu-Gly-Arg) between the C terminus of the permease and the biotin acceptor domain. PCR primers were designed to introduce a factor Xa site at the N terminus of the biotin acceptor domain and to create a new Sal I site downstream of the termination codon. The ends of the PCR product were trimmed with Sal I. Screening of the ligation products for correct insertion orientation identified plasmid pLacY/CXB (Fig. 1 Left). One hundred nanograms of pLacY/CB DNA was used as template with 100 pmol of each primer for 50 PCR cycles utilizing 1 unit of Taq DNA polymerase in buffer with 0.2 mM dNTPs. The thermal cycle was as follows: denature at 94°C for 30 sec, ramp anneal to 37°C over 2 min, 30 sec to 72°C, and extension at 72°C for 30 sec. An identical PCR protocol was used for the construct described below.
(iii) Permease with afactorXa site and the biotin acceptor domain in loop 6 (L6XB permease). A general strategy was devised to insert the biotin acceptor domain into any position in lactose permease-in this case, the middle cytoplasmic loop. First, a unique Sal I site was introduced changing codons 194 and 195 of lacY in pGM21 by two-stage PCR mutagenesis. The 2.3-kb EcoRI fragment encoding mutated lacY (S194V/A195D) was subcloned into the unique EcoRI site of pKRO (derived from pKR35 by removal of the BamHIHindIII DNA fragment encoding the biotin acceptor domain). Second, pLacY/CXB was used as a template with synthetic PCR primers appropriate for amplifying the DNA encoding the factor Xa protease site and the biotin acceptor domain. The primers were also designed to remove the termination codon and introduce a second in-frame Sal I site at the 3' end of the fragment. After digestion of the PCR product with Sal I, a 0.3-kb DNA fragment encoding the factor Xa protease site and the biotin acceptor domain flanked by Sal I sites was obtained. The fragment was then ligated into the newly created, unique Sal I site within lacY. Ligation products were screened by restriction fragment analysis to verify the orientation offragment insertion, yielding pLacY/L6XB (Fig. 1 Right) .
DNA Sequencing. Double-stranded DNA sequencing (21) was carried out by the dideoxynucleotide termination method (22, 23) .
Colony Morphology. E. coli HB101 (lacZ+ Y-) was transformed with plasmids encoding given constructs, and the cells were grown on MacConkey indicator plates containing 25 mM lactose.
Lactose Transport in Cells and Right-Side-Out (RSO) Vesicles. Lactose transport was measured in E. coli T184 harboring given plasmids as described (24) . Transport assays with RSO membrane vesicles were carried out with ascorbate/phenazine methosulfate under oxygen (25, 26) . In both cases, [1-14C] lactose (10 mCi/mmol; 1 Ci = 37 GBq) was used at a final concentration of 0.4 mM, and radioactivity was assayed by liquid scintillation spectrometry.
SDS/PAGE and Blotting. Freshly grown cells were washed in 50 mM potassium phosphate (KP1, pH 7.5) and resuspended to an OD420 of 10, and 1.0-ml aliquots were disrupted by sonication. Undisrupted cells were removed by low-speed centrifugation, and membranes were harvested by 30 min ultracentrifugation in a Beckman Airfuge (28 psi). Samples were dissolved in sample buffer at room temperature and subjected to electrophoresis using 12% and 5% polyacrylamide, respectively, in the running and stacking gels (5). Immunoblotting was carried out as described (27) , except that PA-HRP with ECL was used to detect immune complexes. Alternatively, avidin-HRP with ECL substrates was used to detect biotinylated proteins.
Purification and Reconstitution of Biotinylated Lactose Permease. E. coli T184 harboring plasmid pLacY/L6XB was grown and induced [=20 g (wet weight) of cells], and membranes were prepared as described (5 Transport assays were terminated at a given time by quenching of the reactions with 3 ml of ice-cold 50 mM NaP, (pH 7.5) and immediate filtration. The filters were washed once with the same cold buffer, and radioactivity retained was measured by liquid scintillation spectrometry. Fluorescence of dansylaminohexyl ,B-D-thiogalactopyranoside (Dns-Gal) was also measured (5). Proteoliposomes were concentrated 5-fold in 50 mM KPi (pH 7.5) and diluted 200-fold into a cuvette containing 50 mM NaP, (pH 7.5) and 5 AM Dns-Gal. A membrane potential (interior negative) was then generated by addition of 20 ,uM valinomycin. Where indicated, 20 p.M carbonylcyanide m-chlorophenylhydrazone (CCCP) was added. In control experiments, proteoliposomes were diluted into 50 mM KP, (pH 7.5). Fluorescence was recorded with an Aminco SLM 8000C spectrofluorimeter using 1 x 1-cm cuvettes. Excitation was at 340 nm, and emission was measured at 500 nm. The sample chamber was maintained at 25°C with a circulating water bath.
Protein Determination. Protein was assayed by a modified Lowry procedure (28) .
RESULTS
Verification of Constructs by DNA Sequencing. Genetic constructs were verified by sequencing through all of the ligation junctions in double-stranded DNA.
Colony Morphology. The ability of the constructs to translocate lactose "downhill" was estimated by transforming E. coli HB101 (lacZ+Y-) with pLacY/L6XB or pLacY/CXB and growing the transformants on MacConkey indicator plates containing 25 mM lactose. Cells expressing functional lactose permease hydrolyze the imported lactose, and metabolism of the monosaccharides released causes acidification which makes the colonies appear red. Cells Fig. 2 . Clearly, cells with either chimera transport lactose at initial rates and to steady-state levels of accumulation that are identical to those of wild-type permease within experimental error, while cells transformed with plasmid devoid of lacY transport the disaccharide to a negligible extent.
Similarly, RSO membrane vesicles containing the loop 6 chimera or the C-terminal fusion protein catalyze active lactose transport (data not shown). In the absence of electron donors, vesicles containing no permease, wild-type permease, or each of the constructs accumulate little lactose. On addition of ascorbate/phenazine methosulfate, however, vesicles containing wild-type, L6XB, or CXB permease accumulate lactose rapidly and achieve a steady-state level of accumulation in 3-5 min. In contrast, vesicles without permease are unaffected by addition of electron donor.
Membrane Insertion, Biotinylation, and Topology. Membrane insertion, biotinylation, and the topology of the inserted domains in each construct were evaluated by Western blot analyses using monoclonal antibody (mAb) 4A1OR (27) and PA-HRP or avidin-HRP (Fig. 3) . Membranes containing the loop 6 chimera or the C-terminal fusion protein react with avidin-HRP, demonstrating that the constructs are biotinylated in vivo. No other biotinylated proteins are observed in the membranes (data not shown). The fusion proteins exhibit molecular masses of about 48 and 45 kDa, respectively, whereas wild-type permease apparent or relative exhibits a molecular mass of 33 kDa. In addition, while both proteins react with mAb 4A1OR, L6XB permease reacts with anti-C terminus polyclonal antibody (27) , whereas CXB permease does not (data not shown). Thus, the C terminus of the permease is apparently inaccessible in the C-terminal fusion protein.
The factor Xa site in each chimera is exclusively accessible from the cytoplasmic surface of the membrane. When spheroplasts containing either construct are prepared under conditions where the external surface of the cytoplasmic membrane is accessible to antibody (29) and exposed to factor Xa, minimal cleavage is observed. In marked contrast, when the spheroplasts are disrupted by sonication, the factor Xa sites in both chimeric proteins become completely susceptible to cleavage by the protease. Similar results are obtained when binding of avidin is measured directly (K.H.Z., T.G.C., and H.R.K., unpublished work).
[35S]Methionine pulse-chase experiments (30) Proc. Natl. Acad. Sci. USA 90 (1993) 32.5 and extracted directly with OG. The extract was then applied to a 5-ml avidin-Sepharose column, and unbound protein was eluted by extensive washing with column buffer (Fig. 4A) .
When A280 of the eluate returned to baseline, bound material was eluted with 2 mM (+)-biotin, and shortly thereafter, a sharp peak was observed. As shown by silver staining (Fig.  4B) , the 280-nm-absorbing material eluted with biotin exhibits a major band at :45 kDa with higher-order aggregates at 90 kDa and 135 kDa. Importantly, banding patterns identical to those observed with silver staining are obtained with avidin-HRP or mAb 4A1OR (data not shown), thereby demonstrating that the bands observed at higher molecular mass are indeed aggregates of L6XB permease rather than contaminants. Further, with dodecyl maltoside in place of OG, almost all of the material migrates at 45 kDa (Fig. 4B) , and similar results are obtained when membranes are subjected to SDS/PAGE directly (i.e., without OG extraction; see Fig. 3 ). Thus, the material obtained in the biotin eluate represents highly purified protein. Starting from -20 g of cells (wet weight), =2 mg of purified permease was obtained.
The fractions eluted with biotin were pooled, reconstituted with E. coli phospholipids, and subjected to freeze-thaw/ sonication to prepare proteoliposomes (5) . When proteoliposomes prepared in KPi (pH 7.5) are diluted into NaPi (pH 5.5) in the presence of valinomycin so that a ATIH+ (interior negative and alkaline) is created, lactose is taken up rapidly, and a maximum level of accumulation is observed in 1-2 min (pH 7.5); e, proteoliposomes preincubated with 2 mM p-chloromercuribenzenesulfonate for 10 min at room temperature and subsequently diluted into NaPi (pH 5.5).
( Fig. 5) . The level then decreases gradually due to dissipation Of ASH+. Lactose accumulation is not observed when the proteoliposomes are diluted into equimolar KPi (pH 7.5) or after treatment with p-chloromercuribenzenesulfonate.
Dns-Gal fluorescence studies were performed (5) to obtain independent confirmation for the functionality of purified L6XB (Fig. 6) ..i a acceptor domain fusion approach described by Cronan (14) , we have purified milligram quantities of functional lactose permease by detergent extraction of membranes, followed by a single column step using immobilized monovalent avidin. This report describes two chimeric forms of lactose permease, L6XB and CXB, with factor Xa protease sites at the N termini of the biotin acceptor domains. Both constructs are fully active in cells and RSO membrane vesicles, biotinylated in vivo, and stable after insertion into the membrane. Moreover, L6XB permease catalyzes active transport after purification and reconstitution into proteoliposomes. Although data are not presented, the CXB permease has also been purified with the same protocol, and in this case, the biotin acceptor domain can be removed by treatment with factor Xa. A preliminary report (12) describing the efficacy of the general approach for spectroscopic experiments with singleor double-cysteine replacement mutants has been presented.
Although we have not intensively studied the yield of permease obtained from the purification, it is unlikely that maximal conditions have been achieved. As indicated, 12 mg of purified L6XB permease was obtained from 20 g (wet weight) of cells. If the permease comprises about 10% of the total membrane protein under the conditions utilized, a yield of about 20% can be calculated (i.e., 20 g wet weight 1 g of protein 0.1 g of membrane protein = 0.01 g of permease).
To some extent, the relatively low yield may be due to incomplete biotinylation. Consistently, L6XB permease in sonicated membrane preparations incorporates a significant amount of [14C]biotin when incubated in the presence of purified biotin ligase. Therefore, by increasing the extent of biotinylation in vivo or in vitro, higher yields may be obtained. In any case, ease of preparation, the high state of purity of the material obtained, and the ability to elute the protein in relatively high concentrations at specified protein/ phospholipid ratios in any chosen detergent make the procedure highly attractive. The observations that L6XB and CXB permeases are biotinylated and that the constructs are digested by factor Xa from only the cytoplasmic surface of the membrane are consistent with other experiments (1, 2, 7, 27) demonstrating that both the middle hydrophilic domain of the permease and the C terminus are on the cytoplasmic face of the membrane. The results suggest that the construction of chimeras with the biotin acceptor domain inserted into various hydrophilic domains might be useful for studying the topology of polytopic membrane proteins. However, additional experiments (K.H.Z., T.G.C., and H.R.K., unpublished work) indicate that this is probably not the case. Although the N terminus of the permease is on the cytoplasmic face of the membrane (1, 2, 7, 31) , when the biotin acceptor domain is placed at the N terminus, the chimera is not biotinylated but active transport is observed in cells expressing the construct. Furthermore, constructs with the factor Xa site and the biotin acceptor domain in loop 3 or 7 [loops that are on the periplasmic face of the membrane (1, 2, 7, 31)] are biotinylated. However, both constructs are inactive, and the factor Xa sites are accessible from the cytoplasmic face of the membrane but not from the periplasmic face. Thus, it appears that the presence of the biotinylation domain may block insertion of portions of the polypeptide, a finding that may be related to the run of Ala-Pro repeats at the N terminus of the domain (32) . Therefore, although insertion of biotin acceptor domains may not be useful for studying the topology of polytopic membrane proteins per se, the approach may yield interesting information regarding the mechanism of insertion.
